A tumor is a growth that develops when damage to a cell’s DNA causes it to copy itself excessively, forming a mass. Neuroendocrine tumors (NETs) can be either malignant, meaning they can grow ...

Background: Previous analyses have demonstrated that a neuroendocrine tumor's site of origin correlates with tumor biology, clinical presentation, and oftentimes prognosis. There is however limited ...

Modlin, IM, Kidd M, Frilling A, et al. Molecular genomic assessment using a blood-based mRNA Signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence with 94% accuracy.

Shibuma, S., et al. (2025) Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.

The retrospective study, conducted at the University of Utah Huntsman Cancer Institute, used Biocept’s CNSide assay to detect and analyze tumor cells in the cerebrospinal fluid of 15 unique ...

In 2023, ASCO published a guideline on systemic therapy for tumor control in well-differentiated metastatic grade 1 to grade 3 (G1-G3) GI and pancreatic neuroendocrine tumors (GEP-NETs; Fig 1). 1 This ...